Iradimed (IRMD) Net Margin Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,144.00 |
| Dec 31, 2025 | 2,093.00 |
| Sep 30, 2025 | 1,234.00 |
| Jun 30, 2025 | 5,938.00 |
| Mar 31, 2025 | 363.00 |
| Dec 31, 2024 | -322.00 |
| Sep 30, 2024 | 291.00 |
| Jun 30, 2024 | 470.00 |
| Mar 31, 2024 | 163.00 |
| Dec 31, 2023 | -260.00 |
| Sep 30, 2023 | -82.00 |
| Jun 30, 2023 | 754.00 |
| Mar 31, 2023 | 1,018.00 |
| Dec 31, 2022 | 2,198.00 |
| Sep 30, 2022 | 2,218.00 |
| Jun 30, 2022 | 1,901.00 |
| Mar 31, 2022 | 2,472.00 |
| Dec 31, 2021 | 2,327.00 |
| Sep 30, 2021 | 328.00 |
| Jun 30, 2021 | -763.00 |
| Mar 31, 2021 | -1,042.00 |
| Dec 31, 2020 | -1,987.00 |
| Sep 30, 2020 | -883.00 |
| Jun 30, 2020 | -5,436.00 |
| Mar 31, 2020 | -89.00 |
| Dec 31, 2019 | 2,688.00 |
| Sep 30, 2019 | 1,841.00 |
| Jun 30, 2019 | 97.00 |
| Mar 31, 2019 | 716.00 |
| Dec 31, 2018 | 676.00 |
| Sep 30, 2018 | 2,101.00 |
| Jun 30, 2018 | -175.00 |